| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | TRIO POLR3H TUT7 LRRK2 OAS2 DAPK1 PFKP MAP3K4 PRKAG3 JAK3 PHKG1 PARP4 LIMK1 FES DCLK3 PAK3 PIP5K1B PRKDC CDK1 FAM20A MAP4K4 EIF2AK3 | 8.25e-05 | 938 | 189 | 22 | GO:0016772 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | TRIO LRRK2 DAPK1 MAP3K4 PRKAG3 PHKG1 LIMK1 DCLK3 PAK3 PRKDC CDK1 FAM20A MAP4K4 EIF2AK3 | 9.35e-05 | 446 | 189 | 14 | GO:0004674 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | TRIO LRRK2 DAPK1 PFKP MAP3K4 PRKAG3 JAK3 PHKG1 LIMK1 FES DCLK3 PAK3 PIP5K1B PRKDC CDK1 FAM20A MAP4K4 EIF2AK3 | 1.44e-04 | 709 | 189 | 18 | GO:0016773 |
| GeneOntologyMolecularFunction | protein serine kinase activity | TRIO LRRK2 DAPK1 MAP3K4 PHKG1 LIMK1 DCLK3 PAK3 PRKDC CDK1 MAP4K4 EIF2AK3 | 1.85e-04 | 363 | 189 | 12 | GO:0106310 |
| GeneOntologyMolecularFunction | protein kinase activity | TRIO LRRK2 DAPK1 MAP3K4 PRKAG3 JAK3 PHKG1 LIMK1 FES DCLK3 PAK3 PRKDC CDK1 FAM20A MAP4K4 EIF2AK3 | 1.97e-04 | 600 | 189 | 16 | GO:0004672 |
| GeneOntologyMolecularFunction | kinase activity | TRIO LRRK2 DAPK1 PFKP MAP3K4 PRKAG3 JAK3 PHKG1 LIMK1 FES DCLK3 PAK3 PIP5K1B PRKDC CDK1 FAM20A MAP4K4 EIF2AK3 | 3.57e-04 | 764 | 189 | 18 | GO:0016301 |
| Domain | Patatin | 7.81e-05 | 9 | 186 | 3 | PF01734 | |
| Domain | PNPLA | 7.81e-05 | 9 | 186 | 3 | PS51635 | |
| Domain | Patatin/PLipase_A2-rel | 7.81e-05 | 9 | 186 | 3 | IPR002641 | |
| Domain | Cyt_P450_E_grp-I_CYP2D-like | 9.86e-05 | 2 | 186 | 2 | IPR008069 | |
| Domain | UPF0028 | 9.86e-05 | 2 | 186 | 2 | PS01237 | |
| Domain | Single_hybrid_motif | 2.00e-04 | 12 | 186 | 3 | IPR011053 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | SART3 FLNB RPL32 KIF1A HSPA4L GPX8 HUWE1 PFKP ANKHD1 NPLOC4 CRKL PDIA4 ACSL1 TRMT10C PTPRK P4HB DDX54 ANKRD17 BOLA2 PRKDC CDK1 SIPA1L2 GCN1 ATP2B1 XPR1 | 1.80e-10 | 974 | 191 | 25 | 28675297 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SART3 FLNB RPL32 KIF1A TRIO HSPA4L SYNE1 URB2 API5 HUWE1 ANKHD1 CRKL HNRNPU PDIA4 TRMT10C P4HB DDX54 DOCK7 CTNNBL1 CENPV BOLA2 PRKDC CDK1 PC DDX21 MAP4K4 GCN1 ATP2B1 TOP2B | 1.24e-09 | 1425 | 191 | 29 | 30948266 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | FLNB TRIO TUT7 PARP4 ARHGEF40 DOCK7 MTTP ANKRD17 PRKDC HERC2 GCN1 TOP2B | 1.48e-09 | 202 | 191 | 12 | 33005030 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PNPLA2 MORN1 TRIO WNT7B FBRSL1 PER1 HUWE1 ITGA5 ANKHD1 TBC1D24 JAK3 ARHGEF40 PNPLA6 CTDP1 DIP2C LRP5 CENPV MICAL3 PRKDC HERC2 SIPA1L2 ZNF839 PC GCN1 | 1.11e-08 | 1105 | 191 | 24 | 35748872 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SART3 FLNB DIS3L2 GPX8 TUT7 URB2 HUWE1 PFKP ANKHD1 HNRNPU ACSL1 PCGF6 ARHGEF40 PNPLA6 P4HB MICAL2 DDX54 CTNNBL1 ANKRD17 PRKDC CDK1 HERC2 DDX21 GCN1 ATP2B1 TOP2B | 3.08e-08 | 1353 | 191 | 26 | 29467282 |
| Pubmed | SART3 RPL32 MAGOH HSPA4L SYNE1 PFKP PIGU PDHX PDIA4 USP31 PCGF6 TRMT10C PNPLA6 P4HB CLPTM1 DDX54 CENPV BOLA2 HERC2 C9orf72 SIPA1L2 DDX21 MAP4K4 ATP2B1 EIF2AK3 TOP2B XPR1 | 5.18e-08 | 1487 | 191 | 27 | 33957083 | |
| Pubmed | SART3 FLNB SYN3 TRIO PER1 TACC2 HUWE1 PDHX CRKL HNRNPU TBC1D24 TRMT10C P4HB DOCK7 PAK3 BOLA2 SIPA1L2 PC MAP4K4 GCN1 ALDH5A1 ELP4 AKAP7 | 8.60e-08 | 1139 | 191 | 23 | 36417873 | |
| Pubmed | RPL32 OAS2 ANO10 API5 HUWE1 PFKP PIGU HNRNPU ACSL1 PARP4 PNPLA6 CLPTM1 DDX54 CTNNBL1 ANKRD17 PRKDC CDK1 HERC2 DDX21 ALG6 GCN1 ATP2B1 EIF2AK3 | 1.34e-07 | 1168 | 191 | 23 | 19946888 | |
| Pubmed | SART3 FLNB KIF1A TUT7 URB2 HUWE1 PFKP ANKHD1 PDIA4 P4HB DDX54 DOCK7 ANKRD17 PRKDC HERC2 DDX21 GCN1 | 1.43e-07 | 653 | 191 | 17 | 22586326 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FLNB SLC9A8 KIF1A MORN1 TRIO WNT7B FBRSL1 HUWE1 NPLOC4 HNRNPU NIT2 THAP4 PNPLA6 MICAL2 AUTS2 DIP2C PAK3 ANKRD17 LRP5 KATNIP MICAL3 PNPLA7 TMEM143 ZNF839 MLPH ATP2B1 | 2.00e-07 | 1489 | 191 | 26 | 28611215 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | KIF1A HSPA4L GPX8 HS6ST2 TUT7 URB2 HUWE1 PFKP PDIA4 ARHGEF40 PPP2R5E CTPS2 PNPLA6 PTPRK CLPTM1 ANKRD17 PRKDC TMEM143 GCN1 IPO11 | 2.90e-07 | 942 | 191 | 20 | 31073040 |
| Pubmed | 1.62e-06 | 5 | 191 | 3 | 21715554 | ||
| Pubmed | FLNB MAGOH MOGAT1 HSPA4L MYH7B VPS4B HUWE1 PDHX HNRNPU PDIA4 TRMT10C P4HB CLPTM1 PRKDC CDK1 GCN1 ATP2B1 IPO11 | 1.92e-06 | 878 | 191 | 18 | 37223481 | |
| Pubmed | ACSL6 SYNE1 FSTL5 URB2 MAP3K4 USP31 PPP2R5E DOCK7 KATNIP MICAL3 SIPA1L2 DOP1B | 2.96e-06 | 407 | 191 | 12 | 12693553 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | SART3 FLNB POLR3H VPS4B HUWE1 PFKP NPLOC4 CRKL TRMT10C CTPS2 TRMT2A TIPIN DOCK7 ANKRD17 CDK1 HERC2 MAP4K4 GCN1 AKAP7 | 3.20e-06 | 1005 | 191 | 19 | 19615732 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ITGA11 SUSD6 HSPA4L GPX8 HS6ST2 TUT7 CNTNAP3 TMTC2 ITGA5 PIGU PDIA4 PTPRK P4HB MICAL2 CLPTM1 DPY19L4 LRP5 BOLA2 ALG6 ATP2B1 EIF2AK3 | 3.21e-06 | 1201 | 191 | 21 | 35696571 |
| Pubmed | 3.22e-06 | 6 | 191 | 3 | 30504831 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | RPL32 GPX8 SLFN5 URB2 ANO10 ITGA5 HNRNPU TBC1D24 PDIA4 ZNF800 PPP2R5E PTPRK P4HB MICAL2 CLPTM1 DOCK7 AUTS2 PRKDC CDK1 ATP2B1 TOP2B | 3.29e-06 | 1203 | 191 | 21 | 29180619 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | SART3 FLNB RPL32 HSPA4L TACC2 HUWE1 PFKP ANKHD1 NPLOC4 CRKL HNRNPU TRMT10C CTPS2 P4HB DDX54 CTNNBL1 BOLA2 PRKDC CDK1 PC DDX21 GCN1 TOP2B | 3.57e-06 | 1415 | 191 | 23 | 28515276 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | FLNB SYNE1 URB2 HUWE1 PFKP CRKL HNRNPU PDIA4 P4HB DDX54 DOCK7 PRKDC CDK1 HERC2 DDX21 MAP4K4 GCN1 ATP2B1 TOP2B | 4.19e-06 | 1024 | 191 | 19 | 24711643 |
| Pubmed | SART3 ACSL6 FLNB RPL32 SYN3 TRIO HSPA4L SYNE1 DAPK1 PFKP PDHX HNRNPU TBC1D24 USP31 PPP2R5E PNPLA6 P4HB MICAL2 DOCK7 MICAL3 SIPA1L2 PC ATP2B1 | 4.29e-06 | 1431 | 191 | 23 | 37142655 | |
| Pubmed | LRF maintains genome integrity by regulating the non-homologous end joining pathway of DNA repair. | 5.05e-06 | 79 | 191 | 6 | 26446488 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SART3 ERCC1 HSPA4L TUT7 HUWE1 MAP3K4 DDX54 ANKRD17 CDK1 HERC2 EIF2AK3 TOP2B | 6.53e-06 | 440 | 191 | 12 | 34244565 |
| Pubmed | 8.41e-06 | 183 | 191 | 8 | 23956138 | ||
| Pubmed | Human Elongator facilitates RNA polymerase II transcription through chromatin. | 8.95e-06 | 8 | 191 | 3 | 11818576 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | SART3 URB2 HUWE1 PFKP ANKHD1 MAP3K4 HNRNPU CTPS2 CTNNBL1 ANKRD17 PRKDC CDK1 PC GCN1 TOP2B | 9.07e-06 | 704 | 191 | 15 | 29955894 |
| Pubmed | FLNB HSPA4L NPLOC4 CRKL HNRNPU PDIA4 DOCK7 ANKRD17 MICAL3 PRKDC CDK1 MAP4K4 GCN1 ATP2B1 EIF2AK3 | 9.70e-06 | 708 | 191 | 15 | 39231216 | |
| Pubmed | SYNE1 HUWE1 HNRNPU PDIA4 TRMT10C P4HB CENPV PRKDC CDK1 DDX21 GCN1 ATP2B1 | 1.09e-05 | 463 | 191 | 12 | 34901782 | |
| Pubmed | Comparative mapping of the region of human chromosome 7 deleted in williams syndrome. | 1.34e-05 | 9 | 191 | 3 | 10330122 | |
| Pubmed | 1.34e-05 | 9 | 191 | 3 | 19029121 | ||
| Pubmed | SART3 TUT7 FBRSL1 ANKHD1 NPLOC4 HNRNPU PARP4 ARHGEF40 TRMT2A DOCK7 ANKRD17 MICAL3 PZP MAP4K4 | 1.61e-05 | 650 | 191 | 14 | 38777146 | |
| Pubmed | 1.72e-05 | 202 | 191 | 8 | 24639526 | ||
| Pubmed | SART3 RPL32 PFKP ANKHD1 CRKL HNRNPU ZNF800 DDX54 ANKRD17 BOLA2 PRKDC PC DDX21 GCN1 | 1.76e-05 | 655 | 191 | 14 | 35819319 | |
| Pubmed | HUWE1 PIGU NPLOC4 HNRNPU PCGF6 P4HB CLPTM1 PRKDC CDK1 HERC2 DDX21 GCN1 IPO11 SLC16A10 | 1.82e-05 | 657 | 191 | 14 | 36180527 | |
| Pubmed | FLNB RPL32 HSPA4L TUT7 PFKP ANKHD1 HNRNPU PPP2R5E CTPS2 ANKRD17 DDX21 | 1.90e-05 | 411 | 191 | 11 | 36652389 | |
| Pubmed | Real-time resolution of point mutations that cause phenovariance in mice. | 1.90e-05 | 10 | 191 | 3 | 25605905 | |
| Pubmed | Characterization of the human patatin-like phospholipase family. | 1.90e-05 | 10 | 191 | 3 | 16799181 | |
| Pubmed | A role of DNA-PK for the metabolic gene regulation in response to insulin. | 1.90e-05 | 10 | 191 | 3 | 19303849 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | SART3 FLNB HSPA4L GPX8 API5 PFKP HNRNPU PDIA4 TRMT10C ANKRD17 LRP5 PRKDC CDK1 DDX21 MAP4K4 ATP2B1 | 2.00e-05 | 847 | 191 | 16 | 35235311 |
| Pubmed | 2.16e-05 | 30 | 191 | 4 | 32867711 | ||
| Pubmed | FLNB VPS4B RUSC1 HUWE1 ANKHD1 CRKL DOCK7 ANKRD17 BOLA2 PC GCN1 | 2.21e-05 | 418 | 191 | 11 | 34709266 | |
| Pubmed | KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer. | 2.46e-05 | 104 | 191 | 6 | 36055981 | |
| Pubmed | 2.78e-05 | 64 | 191 | 5 | 22865885 | ||
| Pubmed | Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity. | 3.00e-05 | 2 | 191 | 2 | 12640454 | |
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 23475612 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 2295602 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 2991590 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 20224305 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 24012878 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 23861867 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 10548543 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 26807827 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 16478722 | ||
| Pubmed | Stromal Integrin α11β1 Affects RM11 Prostate and 4T1 Breast Xenograft Tumors Differently. | 3.00e-05 | 2 | 191 | 2 | 26990302 | |
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 26279433 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 8111381 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 31150793 | ||
| Pubmed | DIS3L2 Promotes Progression of Hepatocellular Carcinoma via hnRNP U-Mediated Alternative Splicing. | 3.00e-05 | 2 | 191 | 2 | 31331910 | |
| Pubmed | Death-associated protein kinase 1 variation and Parkinson's disease. | 3.00e-05 | 2 | 191 | 2 | 21749573 | |
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 18086666 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 19351595 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 21450944 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 18385213 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 23588498 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 16834775 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 39269294 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 35627777 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 12060584 | ||
| Pubmed | 3.08e-05 | 285 | 191 | 9 | 32838362 | ||
| Pubmed | PFKP ANKHD1 TRMT10C PNPLA6 DOCK7 CENPV PRKDC CDK1 PC DDX21 MAP4K4 GCN1 TOP2B | 3.12e-05 | 601 | 191 | 13 | 33658012 | |
| Pubmed | 3.46e-05 | 12 | 191 | 3 | 9027489 | ||
| Pubmed | Protein phosphatase 2A protects centromeric sister chromatid cohesion during meiosis I. | 3.46e-05 | 12 | 191 | 3 | 16541024 | |
| Pubmed | 4.04e-05 | 35 | 191 | 4 | 22337587 | ||
| Pubmed | FLNB HUWE1 PFKP ANKHD1 PDIA4 DOCK7 ANKRD17 PRKDC DDX21 GCN1 ATP2B1 ALDH5A1 | 4.38e-05 | 534 | 191 | 12 | 35032548 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | SART3 FLNB MAGOH SYNE1 TUT7 FBRSL1 API5 ANKHD1 HNRNPU TRMT10C P4HB DDX54 PRKDC DDX21 GCN1 | 4.39e-05 | 807 | 191 | 15 | 22681889 |
| Pubmed | SART3 ITGA11 ERCC1 GPX8 TRPC4 TUT7 LRRK2 RUSC1 DAPK1 TACC2 ANO10 ARSI ARSL GRIFIN MICAL3 HERC2 SIPA1L2 PC EIF2AK3 | 4.45e-05 | 1215 | 191 | 19 | 15146197 | |
| Pubmed | RPL32 SLC9A8 PDHX CRKL HNRNPU TRMT10C P4HB DOCK7 CENPV BOLA2 PRKDC CDK1 DDX21 GCN1 ALDH5A1 | 4.51e-05 | 809 | 191 | 15 | 32129710 | |
| Pubmed | 4.92e-05 | 72 | 191 | 5 | 36376293 | ||
| Pubmed | SART3 RPL32 HSPA4L API5 HUWE1 ANKHD1 NPLOC4 CRKL HNRNPU TRMT10C PPP2R5E CTPS2 P4HB TIPIN CTNNBL1 PRKDC CDK1 PC DDX21 ELP4 | 5.05e-05 | 1335 | 191 | 20 | 29229926 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | HUWE1 PDHX HNRNPU TRMT10C PPP2R5E PNPLA6 DDX54 DOCK7 ANKRD17 PRKDC HERC2 SIPA1L2 DDX21 | 5.82e-05 | 639 | 191 | 13 | 23443559 |
| Pubmed | 6.21e-05 | 312 | 191 | 9 | 37120454 | ||
| Pubmed | 6.36e-05 | 313 | 191 | 9 | 20800603 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | SART3 FLNB RPL32 HSPA4L API5 HUWE1 PFKP ANKHD1 HNRNPU PDIA4 LRRIQ1 P4HB DOCK7 ANKRD17 MICAL3 PRKDC CDK1 GCN1 | 6.97e-05 | 1149 | 191 | 18 | 35446349 |
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | 7.02e-05 | 182 | 191 | 7 | 31067453 | |
| Pubmed | 7.07e-05 | 15 | 191 | 3 | 29968852 | ||
| Pubmed | TRIO HUWE1 ITGA5 PDIA4 USP31 TRMT10C PPP2R5B PPP2R5E PTPRK P4HB DDX54 MICAL3 CDK1 HERC2 PC GCN1 ATP2B1 | 7.41e-05 | 1049 | 191 | 17 | 27880917 | |
| Pubmed | 7.54e-05 | 397 | 191 | 10 | 21319273 | ||
| Pubmed | MAGOH ANO10 ITGA5 PDIA4 TRMT10C P4HB CLPTM1 DDX54 CENPV BOLA2 CDK1 MAP4K4 ALG6 ATP2B1 EIF2AK3 SLC16A10 | 7.98e-05 | 952 | 191 | 16 | 38569033 | |
| Pubmed | 8.09e-05 | 323 | 191 | 9 | 24797263 | ||
| Pubmed | 8.47e-05 | 253 | 191 | 8 | 29911972 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | CNTNAP3B PNPLA2 GPX8 CNTNAP3 HUWE1 PFKP PIGU PDHX NPLOC4 BROX ARSL DPY19L4 PRKDC PC ALG6 ALDH5A1 IPO11 | 8.50e-05 | 1061 | 191 | 17 | 33845483 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | RPL32 TUT7 TACC2 URB2 PDHX HNRNPU DDX54 CENPV PRKDC CDK1 HERC2 DDX21 GCN1 TOP2B | 8.58e-05 | 759 | 191 | 14 | 35915203 |
| Pubmed | Colitis susceptibility in p47(phox-/-) mice is mediated by the microbiome. | 8.97e-05 | 3 | 191 | 2 | 27044504 | |
| Pubmed | NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury. | 8.97e-05 | 3 | 191 | 2 | 18787174 | |
| Pubmed | 8.97e-05 | 3 | 191 | 2 | 24873968 | ||
| Pubmed | 8.97e-05 | 3 | 191 | 2 | 22184329 | ||
| Pubmed | Natural Loss-of-Function Mutations in Qa2 and NCF1 Cause the Spread of Mannan-Induced Psoriasis. | 8.97e-05 | 3 | 191 | 2 | 33545139 | |
| Pubmed | Small-molecule screen identifies reactive oxygen species as key regulators of neutrophil chemotaxis. | 8.97e-05 | 3 | 191 | 2 | 20142487 | |
| Pubmed | p47(phox) contributes to albuminuria and kidney fibrosis in mice. | 8.97e-05 | 3 | 191 | 2 | 25565313 | |
| Pubmed | Fes mediates the IL-4 activation of insulin receptor substrate-2 and cellular proliferation. | 8.97e-05 | 3 | 191 | 2 | 11160325 | |
| Interaction | LRRC31 interactions | FLNB TRIO TUT7 PARP4 ARHGEF40 DOCK7 MTTP ANKRD17 PRKDC HERC2 GCN1 TOP2B | 4.99e-07 | 205 | 187 | 12 | int:LRRC31 |
| Interaction | FLT1 interactions | MAGOH PFKP CRKL PDIA4 TRMT10C MICAL2 DDX54 PRKDC CDK1 GCN1 DOP1B | 9.37e-07 | 179 | 187 | 11 | int:FLT1 |
| Interaction | DNAJB9 interactions | CNTNAP3B HS6ST2 CNTNAP3 TLR7 PDIA4 PTPRK P4HB CLPTM1 LRP5 RXFP1 | 1.99e-05 | 202 | 187 | 10 | int:DNAJB9 |
| Interaction | SIRT7 interactions | SART3 FLNB KIF1A TUT7 URB2 HUWE1 PFKP ANKHD1 PDIA4 KAT2B P4HB DDX54 DOCK7 CTNNBL1 ANKRD17 PRKDC CDK1 HERC2 DDX21 GCN1 | 2.06e-05 | 744 | 187 | 20 | int:SIRT7 |
| Interaction | PHKG2 interactions | 2.22e-05 | 91 | 187 | 7 | int:PHKG2 | |
| Interaction | MTTP interactions | 2.50e-05 | 19 | 187 | 4 | int:MTTP | |
| Interaction | ITGB3 interactions | 3.07e-05 | 170 | 187 | 9 | int:ITGB3 | |
| Interaction | FGF3 interactions | 3.37e-05 | 66 | 187 | 6 | int:FGF3 | |
| Interaction | LGR4 interactions | DCT PDHX HNRNPU ARHGEF40 LRRIQ1 DOCK7 CYP2U1 PRKDC DDX21 GCN1 ATP2B1 | 3.52e-05 | 262 | 187 | 11 | int:LGR4 |
| GeneFamily | Patatin like phospholipase domain containing | 2.76e-05 | 10 | 113 | 3 | 466 | |
| Coexpression | HEVNER_CORTICAL_PLATE_POSTMITOTIC_NEURONS | 7.02e-06 | 136 | 190 | 8 | MM407 | |
| Coexpression | GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN | 1.64e-05 | 200 | 190 | 9 | M6095 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | GPR155 ACSL6 TRIM2 SYN3 KIF1A HS6ST2 LRRK2 RUSC1 PFKP TBC1D24 FSIP2 SLC8A1 PTPRK CLVS2 DCLK3 AUTS2 PAK3 MICAL3 SPAG17 ATP2B1 DOP1B XPR1 | 1.86e-05 | 1106 | 190 | 22 | M39071 |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 8.47e-08 | 180 | 190 | 9 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.53e-07 | 193 | 190 | 9 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.53e-07 | 193 | 190 | 9 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.60e-07 | 194 | 190 | 9 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.99e-07 | 199 | 190 | 9 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5_RORB_LINC01202|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.66e-07 | 177 | 190 | 8 | b6476a91abd06b8271b4d0ad7431d24b44022b47 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.35e-06 | 185 | 190 | 8 | a7ae76058b2082020cadec49d63b9f4e24d21734 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.78e-06 | 192 | 190 | 8 | 0aeb5351275c0a91151ea2d52b2cdde172da6731 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.78e-06 | 192 | 190 | 8 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 1.85e-06 | 193 | 190 | 8 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.92e-06 | 194 | 190 | 8 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.00e-06 | 195 | 190 | 8 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor | 2.00e-06 | 195 | 190 | 8 | 55e25f702af19146a161861cfd15f40bbda1dc35 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.24e-06 | 198 | 190 | 8 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.24e-06 | 198 | 190 | 8 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.32e-06 | 199 | 190 | 8 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.32e-06 | 199 | 190 | 8 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.41e-06 | 200 | 190 | 8 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.41e-06 | 200 | 190 | 8 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.41e-06 | 200 | 190 | 8 | 851c57187db8bc91a393655bca5f13e787a723d4 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.12e-06 | 157 | 190 | 7 | a98d06cef80bfe8481b0940abce2b29675e45812 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 6.55e-06 | 163 | 190 | 7 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l26|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.10e-06 | 165 | 190 | 7 | 23955e3373660f827518e723ac62fba99753f375 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.30e-05 | 181 | 190 | 7 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 1.44e-05 | 184 | 190 | 7 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.60e-05 | 187 | 190 | 7 | e61c1755531469dd3850c9740474b5ad4e0499c1 | |
| ToppCell | NS-moderate-d_0-4-Myeloid-Non-resident_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.60e-05 | 187 | 190 | 7 | fcc32dbc9c5ae6176f154715a3e73aa32d78ad64 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 1.66e-05 | 188 | 190 | 7 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 1.71e-05 | 189 | 190 | 7 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-05 | 190 | 190 | 7 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.83e-05 | 191 | 190 | 7 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.83e-05 | 191 | 190 | 7 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 1.90e-05 | 192 | 190 | 7 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 1.90e-05 | 192 | 190 | 7 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 2.10e-05 | 195 | 190 | 7 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 2.10e-05 | 195 | 190 | 7 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | AT2_cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 2.10e-05 | 195 | 190 | 7 | 0792c1e959e933b10ae987d821ff43020dfdabad | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 2.24e-05 | 197 | 190 | 7 | 5e0d222872a25bb9e9069d3dffda2844bb69874a | |
| ToppCell | control-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.24e-05 | 197 | 190 | 7 | df2fe36cb96e2565a9d21c24cb4e451e8befd4be | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D231|Adult / Lineage, Cell type, age group and donor | 2.31e-05 | 198 | 190 | 7 | 79a415e19cedde13a88f5043d71557363f102322 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.31e-05 | 198 | 190 | 7 | 06201b34d3e38f22c93b759511f7b376504bac06 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.31e-05 | 198 | 190 | 7 | 1ca91559fef231896e16180f5e050155c38f7cfa | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 2.39e-05 | 199 | 190 | 7 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.39e-05 | 199 | 190 | 7 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 2.39e-05 | 199 | 190 | 7 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.39e-05 | 199 | 190 | 7 | 379bbd9cecf466b902411c54d74bd9885285b1ba | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Mesenchymal-Mesoderm|10w / Sample Type, Dataset, Time_group, and Cell type. | 2.47e-05 | 200 | 190 | 7 | 9ef226ebb0a7cdb9431e2fa65faa2a7d67da590d | |
| ToppCell | mild-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.47e-05 | 200 | 190 | 7 | 934c2efc780318c66d667ca75be0de350361d351 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.47e-05 | 200 | 190 | 7 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P2|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.00e-05 | 84 | 190 | 5 | 1f8b19b159f83655f66cb99f8d10d9a87c08f78f | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P2-Tnr|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.00e-05 | 84 | 190 | 5 | 503490e9408d9638bcd089ef8ec0521924df9a5d | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4_(Bmp4)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.00e-05 | 84 | 190 | 5 | c37e1170d39ad015f724e373a547ea5b6ba45a84 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4_(Bmp4)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.00e-05 | 84 | 190 | 5 | 7e4a76b65b0d34d9950f8b02590ff5a4b4534a27 | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P2-Tnr|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.56e-05 | 87 | 190 | 5 | 0c3a3ed1f279ed29a0113cc73ae590157a4b7334 | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P2|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.56e-05 | 87 | 190 | 5 | a93dbe73b337cc2d93208822728b9badf30b6870 | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4_(Bmp4)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.56e-05 | 87 | 190 | 5 | 45ef27ba84f731e4b2188813cd6931950e5164ac | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4_(Bmp4)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.56e-05 | 87 | 190 | 5 | 5d1dbbd86d82cbce4f2a3365242eb92d9c821a9e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.20e-05 | 148 | 190 | 6 | 9fe3c0a5904b8e9a0f28130f8d84d4f2a819b06c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 5.83e-05 | 157 | 190 | 6 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Macrophage|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.04e-05 | 158 | 190 | 6 | 1635a85fc73c544028418087f36d28957dd4f458 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.04e-05 | 158 | 190 | 6 | 80841dadfa53bcde36a3e486408a095f78e772eb | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 6.71e-05 | 161 | 190 | 6 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-05 | 161 | 190 | 6 | 60f433eab9d5531bdf6aa86b0265f20b866b904c | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_ALM_Oprk1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.94e-05 | 162 | 190 | 6 | 2d28306c6125b31f11ea6d911a167b93a74907c5 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-A_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.43e-05 | 164 | 190 | 6 | 85f53d184fa70e3eb1af655807f32b17ddbfb304 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.43e-05 | 164 | 190 | 6 | 0853e75b60b2a78257b660910c3ee15b09c5f5b0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.43e-05 | 164 | 190 | 6 | f6a961fa2002da7d9679f32af99e1314c0593ef9 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-A_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.43e-05 | 164 | 190 | 6 | 144ba070a1ede71684224cc6d4ead3b7e6a7b4c6 | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.62e-05 | 102 | 190 | 5 | 57ad3d48adeb41f6ab65883e61d3b1e74a94ad1a | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.62e-05 | 102 | 190 | 5 | 9392288e284b71f3a208d9f283e6e3c944b7dd10 | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.62e-05 | 102 | 190 | 5 | 0ec549ee94da5f2d7275490e90d816c645f6d4fc | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.62e-05 | 102 | 190 | 5 | 30fa92383898f370dabc41dd23d6907f14ba1a06 | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.62e-05 | 102 | 190 | 5 | c58e09aaa11b664c7d99e91f903561fa18460f05 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage-macrophage,_alveolar|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.94e-05 | 166 | 190 | 6 | 28a44448a0b0d72459e8fe84ce5d666f16f514b3 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.94e-05 | 166 | 190 | 6 | 2a04915d534a83e65aa168435d6856125b5bdd78 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.94e-05 | 166 | 190 | 6 | 63dc58864268b4e7779e4c45155022556fc634f9 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.94e-05 | 166 | 190 | 6 | c20479fe7a4306320d7f26e78bf956225f00f35a | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP3_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.21e-05 | 167 | 190 | 6 | 49b19159c62d33d65ed1e59a148c11ae902fd41c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.48e-05 | 168 | 190 | 6 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.48e-05 | 168 | 190 | 6 | 073b53d4cee6bc8c5c6fce51cf6cd9c316478f69 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 8.48e-05 | 168 | 190 | 6 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP3_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.77e-05 | 169 | 190 | 6 | d9c3b22f62b882b8a2ea6fd9cf7afbe6d1775745 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-club_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.06e-05 | 170 | 190 | 6 | 6de3778e8257c3330db0780c59238ca501fe5059 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-club_cell-club_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.06e-05 | 170 | 190 | 6 | 60887da674ef1a735bad618235608312d8de63d3 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.35e-05 | 171 | 190 | 6 | 8a0c08f0aa3a80cd6346c81deb242e430ebd897b | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Deuterosomal|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 9.35e-05 | 171 | 190 | 6 | 52aec5f6677fe2f7a36fb5b18117a4cffaeff58f | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.66e-05 | 172 | 190 | 6 | 8d6a2a0d5f63b09a5a304a77e600a647f87e9de4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.66e-05 | 172 | 190 | 6 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.66e-05 | 172 | 190 | 6 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5-6_RORB_LINC00320|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.97e-05 | 173 | 190 | 6 | 4ec147479b359cce1975d57a50ee1437a0e1e663 | |
| ToppCell | wk_20-22-Epithelial-PNS|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 9.97e-05 | 173 | 190 | 6 | 17b1a6b0318925d5d920f2c0a791745b9587ebef | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Promyelocyte-like|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.10e-04 | 176 | 190 | 6 | ee33d7077a92c1fd371081e7c990c7266e711957 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 178 | 190 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-lymphatic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.20e-04 | 179 | 190 | 6 | ab3d08b51cd7a37582305615ee221c7a2af83b40 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.20e-04 | 179 | 190 | 6 | 35fe9961e228ce255e3317fc244efa35b5adbf8b | |
| ToppCell | 15-Distal-Epithelial-Neuroendocrine|Distal / Age, Tissue, Lineage and Cell class | 1.20e-04 | 179 | 190 | 6 | bc04789f0fbd293fdcea66acba8cf227af251b7a | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.28e-04 | 181 | 190 | 6 | fad7ba168f541ac9d04edebc206f191e48bb7e99 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.28e-04 | 181 | 190 | 6 | 136b0c60680068838d184d32aa99d7bea8718dbc | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.32e-04 | 182 | 190 | 6 | 72e65a23cd36085bc880087d3cae92395de918a1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.32e-04 | 182 | 190 | 6 | 05c167158815bf25d509df59ab386e1990712765 | |
| Disease | blindness (implicated_via_orthology) | 1.26e-05 | 8 | 182 | 3 | DOID:1432 (implicated_via_orthology) | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 3.41e-05 | 145 | 182 | 7 | DOID:1289 (implicated_via_orthology) | |
| Disease | age-related macular degeneration, COVID-19 | 6.90e-05 | 69 | 182 | 5 | EFO_0001365, MONDO_0100096 | |
| Disease | cathepsin L1 measurement | 1.22e-04 | 16 | 182 | 3 | EFO_0010619 | |
| Disease | chronic granulomatous disease (implicated_via_orthology) | 3.74e-04 | 5 | 182 | 2 | DOID:3265 (implicated_via_orthology) | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 6.75e-04 | 28 | 182 | 3 | DOID:1094 (implicated_via_orthology) | |
| Disease | cortical surface area measurement | ACSL6 FLNB ITGA11 SLC9A8 TRIM2 PSG1 TUT7 DAPK1 NPLOC4 CRKL PCGF6 PPP2R5E LRRIQ1 FES AUTS2 PLEKHM3 SPAG17 PC MAP4K4 | 6.85e-04 | 1345 | 182 | 19 | EFO_0010736 |
| Disease | synophrys measurement | 8.38e-04 | 68 | 182 | 4 | EFO_0007906 | |
| Disease | non-alcoholic fatty liver disease | 9.61e-04 | 182 | 182 | 6 | EFO_0003095 | |
| Disease | Leigh syndrome | 1.03e-03 | 8 | 182 | 2 | cv:C0023264 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 1.03e-03 | 8 | 182 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 1.03e-03 | 8 | 182 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | Schizophrenia and related disorders | 1.32e-03 | 9 | 182 | 2 | C0809983 | |
| Disease | mean reticulocyte volume | SYN3 PSG1 SUSD6 FBRSL1 URB2 CPN1 NPLOC4 TBC1D24 KAT2B ALG6 AKAP7 IPO11 SLC16A10 | 1.44e-03 | 799 | 182 | 13 | EFO_0010701 |
| Disease | hair colour measurement | MYH7B DCT NPLOC4 FES CTNNBL1 LRP5 CATSPERB HERC2 SIPA1L2 PC AKAP7 | 1.60e-03 | 615 | 182 | 11 | EFO_0007822 |
| Disease | adseverin measurement | 1.65e-03 | 10 | 182 | 2 | EFO_0801358 | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 2.38e-03 | 43 | 182 | 3 | DOID:2476 (implicated_via_orthology) | |
| Disease | Lenticulostriate Disorders | 2.40e-03 | 12 | 182 | 2 | C0750951 | |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 2.40e-03 | 12 | 182 | 2 | DOID:7148 (implicated_via_orthology) | |
| Disease | Extrapyramidal Disorders | 2.40e-03 | 12 | 182 | 2 | C0015371 | |
| Disease | hair colour measurement, hair morphology measurement | 2.40e-03 | 12 | 182 | 2 | EFO_0007821, EFO_0007822 | |
| Disease | Basal Ganglia Diseases | 2.40e-03 | 12 | 182 | 2 | C0004782 | |
| Disease | Uterine leiomyoma | 2.47e-03 | 91 | 182 | 4 | HP_0000131 | |
| Disease | FVC change measurement, response to placebo | 2.82e-03 | 13 | 182 | 2 | EFO_0008344, EFO_0010339 | |
| Disease | bone density | 2.93e-03 | 388 | 182 | 8 | EFO_0003923 | |
| Disease | Adenocarcinoma of large intestine | 2.99e-03 | 96 | 182 | 4 | C1319315 | |
| Disease | Spastic Paraplegia, Hereditary | 3.28e-03 | 14 | 182 | 2 | C0037773 | |
| Disease | early cardiac repolarization measurement | 3.28e-03 | 14 | 182 | 2 | EFO_0004885 | |
| Disease | rectum cancer, overall survival | 3.77e-03 | 15 | 182 | 2 | EFO_0000638, EFO_1000657 | |
| Disease | suntan | 3.85e-03 | 103 | 182 | 4 | EFO_0004279 | |
| Disease | Peripheral Nervous System Diseases | 4.54e-03 | 54 | 182 | 3 | C4721453 | |
| Disease | cardiac troponin I measurement | 4.81e-03 | 176 | 182 | 5 | EFO_0010071 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 4.84e-03 | 17 | 182 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | gamma-aminoisobutyric acid measurement | 6.04e-03 | 19 | 182 | 2 | EFO_0010482 | |
| Disease | ovulation | 6.04e-03 | 19 | 182 | 2 | GO_0030728 | |
| Disease | response to methotrexate, neurotoxicity | 6.04e-03 | 19 | 182 | 2 | EFO_0011057, GO_0031427 | |
| Disease | cholesterol in chylomicrons and extremely large VLDL measurement | 6.10e-03 | 60 | 182 | 3 | EFO_0021898 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FLTLFFLAPELHPKK | 1181 | Q14146 | |
| FALPLKTEHKQFLVR | 266 | Q15173 | |
| GFALPLKAEHKQFLV | 251 | Q16537 | |
| VIIYKVFRHTAGLKP | 591 | Q9HBW9 | |
| IAGFLDPEKKLFSHR | 256 | Q9Y5B0 | |
| PHKLEVGAKLDLFGR | 616 | Q9HCM7 | |
| RIKIIDFGLAHKIDF | 156 | P53355 | |
| FKVTEGKLLRDPLSH | 176 | Q9Y6F7 | |
| HITLELIKGKLVFFL | 231 | Q9BZ76 | |
| FPKILGVLTHLDSFK | 71 | Q5VTM2 | |
| VFLFEHLLLFSKLKG | 1291 | Q8TER5 | |
| SFLKRNKHGPFLLFV | 281 | P51690 | |
| HIFKGIKIFPTVLTF | 346 | Q9H7T0 | |
| HKFVDILGLRTIFPL | 371 | Q8WYA6 | |
| KALAKLEHPGIVRYF | 641 | Q9NZJ5 | |
| ILTHKRLLKFLHIFG | 321 | Q9UGI9 | |
| FRKKVSPAVLVHRDG | 66 | Q13410 | |
| AELGTFPRAFKKLLH | 161 | Q9NUP1 | |
| AIIPAFHFLKSEKGL | 1166 | Q8N7X0 | |
| SFNVFLKIKDILPRH | 281 | Q9Y672 | |
| KGILVGESRSFKPHL | 206 | Q9P0M2 | |
| PNGTLKIIDRKKHIF | 546 | P33121 | |
| LGFVHSPLLKRKQRT | 326 | Q5FYB1 | |
| EGIFLHVTVPRKIKS | 21 | Q9Y3Q7 | |
| DRFLAIVHPVKSLKL | 156 | Q13304 | |
| SAKFEGKPLLQRHRL | 41 | Q9H3K6 | |
| IPAFRTFLKRHDKTI | 681 | Q008S8 | |
| HQLGRKLPDFLTAKL | 351 | Q9BZZ5 | |
| HRDKKGFTPLILAAT | 1111 | O75179 | |
| GVLRINPKKFHEAFI | 71 | Q8IYB7 | |
| VERGLTLHLKFLEPF | 226 | P00736 | |
| IPTSRLKFLKEAGHG | 1061 | P20020 | |
| FIGIDLVKDHLKRTP | 366 | Q8TBG4 | |
| KFKGVFHPVIISPDR | 276 | Q06278 | |
| LKFVKVDSHFRQGIP | 346 | P20742 | |
| LDSKVKRIGPHIEIF | 261 | A0A1B0GVH7 | |
| AHVKIADFGLAKLLP | 961 | P52333 | |
| KFILAFAIPDKPRHI | 606 | Q9NW15 | |
| PFLFLDSLHKKAGGR | 381 | Q5T089 | |
| HPGKFTLFIRQRKGF | 196 | Q96PD6 | |
| RRGSAKELLQHPFLK | 521 | O75914 | |
| EVSKEARKRFLGPLH | 71 | Q96AD5 | |
| KNVRVLGHFEKPLFL | 191 | Q8IY17 | |
| FKSFGELVHKPLLVD | 1061 | O95819 | |
| LGLSAHPKLEKTFFV | 16 | Q8NH95 | |
| LGLSAHPKLEKTFFV | 16 | P0DN81 | |
| PFTIHDLRGLGAKKF | 131 | Q7RTP6 | |
| KLEENLHKLGTFPFR | 56 | Q86XE5 | |
| EFPLGRFHTKKDIKA | 326 | P21941 | |
| KKHFIFGEPRKLITQ | 236 | O15480 | |
| LEKRTLILTHFPKFL | 336 | Q92831 | |
| VSIFKLILRFMGDPH | 2086 | Q9UKN7 | |
| FGLDKHLIILPFKRR | 711 | Q7Z3F1 | |
| RGGKQLLHSPFFKVL | 3836 | O95714 | |
| AKTPHRGVKEFGLLV | 1506 | O60303 | |
| PHTVRILELLKLKFG | 2201 | Q9Y3R5 | |
| CLVFSLIGLHFKIKP | 131 | P61326 | |
| KVLRKLTVNGFVEPH | 216 | Q9UI26 | |
| LGFPLDLQKKLLHFT | 696 | Q5U5R9 | |
| KRRTLLEDKLPHIFG | 536 | O75197 | |
| PAKGKLFLHRVGRVA | 416 | Q8TDD1 | |
| KLADFGLAKHVVRPI | 496 | Q9C098 | |
| QLEHIFPREGIFKKL | 2826 | Q5CZC0 | |
| KARRLFDVLHEPFLK | 281 | P07992 | |
| FIPREVGEHLVSIKK | 1966 | O75369 | |
| KFIRIHFGPSGKLAS | 291 | A7E2Y1 | |
| KVAFVLGRHKVRTAP | 451 | O15534 | |
| VKKEHIPGTLRFRLS | 171 | O00330 | |
| RPTLLHLIHGKVKEF | 121 | P55157 | |
| SRAPKGSLRKFLEHL | 6 | Q01813 | |
| IRHIALLGFEKRFVP | 6 | P14598 | |
| GIPAKSHRGEKLLLF | 331 | O14986 | |
| LLFGDFESPLHKLRK | 256 | Q6P2I7 | |
| LLKIKHGDLLFLFPS | 66 | Q8TAT6 | |
| AFKISKEVLAGRPLF | 431 | Q00839 | |
| HKLDFGLKPEFLSRP | 676 | Q8WXX7 | |
| IAIKELFAGKPVLRH | 201 | Q8N8Q9 | |
| HPKGIISRRDVEKFL | 1621 | Q5S007 | |
| LGKLISIHIKVDPLF | 2371 | Q92616 | |
| IFHGFRGSILKTPKQ | 576 | Q9UKX5 | |
| PKIFGGEIKTHILLF | 246 | P07237 | |
| GEIKTHILLFLPKSV | 251 | P07237 | |
| ELKKQGFLLREHFTP | 221 | Q9UKK3 | |
| LAPFLGKVIKFATSH | 656 | Q6ZWE6 | |
| GRKGLFPFTHVKIFD | 281 | P46109 | |
| FTTPGHLLDKFIKEF | 341 | P29728 | |
| FLKKGLVNDLARVPH | 2216 | Q7Z6Z7 | |
| TIPLAIKLKEHPIFF | 301 | Q9H490 | |
| KNVRVLGHFEKPLFL | 141 | Q6ZV29 | |
| LTKIVPLFHFVSLEK | 1071 | Q96JM4 | |
| IRHIALLGFEKRFVP | 6 | A6NI72 | |
| EFQRHIKPSEKLLGF | 471 | Q8N475 | |
| SGHFREKLFPLFLSI | 216 | Q5TIA1 | |
| EKEKKSPVGLHFLFL | 86 | Q9NZH0 | |
| GLRFTVPHLRDTKKT | 746 | P08648 | |
| FHKALFSPSRIIKEG | 1081 | A1KZ92 | |
| RHFGLGKLSLEPKII | 186 | Q7Z449 | |
| LLLLFKLVAPVTFRH | 11 | P15169 | |
| TGRLPTKKLFHEELA | 976 | Q96N67 | |
| LNIGLFPKDVTHFLK | 236 | Q9HB55 | |
| HLPRIVSYIEKGLFK | 196 | Q8WUS8 | |
| LHIPALAGKVLRFQK | 231 | P10635 | |
| HRIKKLFGFIPGSED | 246 | Q5JW98 | |
| IVPASRFKLLKGAEH | 186 | Q7Z7K6 | |
| PKHVLFQRFAKIFIG | 41 | Q7Z388 | |
| KLFKDLGLHPRAVST | 1281 | Q9Y2E4 | |
| FIKNHAFRLLKPGGV | 151 | Q14353 | |
| LKHVLGAIFSKIFGP | 126 | Q96MM7 | |
| HGFFLPEKISSTLKV | 201 | Q96EB1 | |
| KTFSFAIPLIEKLHG | 236 | Q9NR30 | |
| FLLETGDIAFHIKPR | 36 | A4D1Z8 | |
| GVTFPIFHKIKILGS | 131 | Q8TED1 | |
| LFKPNFGASLHILKV | 86 | P54803 | |
| TSLEKHKLFISGLPF | 796 | Q15020 | |
| LAEKIKPGLHSFIFG | 451 | Q96LT7 | |
| HITLELIKGKLVFFL | 231 | Q96NU0 | |
| PFGSKKKRLLSVHDF | 181 | Q9BV36 | |
| KFQLPGQKLFIRHIT | 371 | P11464 | |
| RVSPIVSKKGYLHFL | 1571 | Q12756 | |
| PFTIHDLRGLGAKKF | 131 | O94851 | |
| HREVPGSKRSFLKLI | 1341 | Q15262 | |
| TGHFKPLEKKFVRVS | 266 | Q9BYE7 | |
| VRHFSPRGKFKVIAL | 296 | Q16816 | |
| ILKSHISGIFRPKFS | 426 | P07332 | |
| LKIFEGIKHPNLVRY | 1391 | Q9Y6R4 | |
| HALVADGLKPFRKDL | 536 | Q9BVN2 | |
| RLKPKHTKLFVFLAV | 86 | Q96A25 | |
| LIKIFHSLGPEKFPL | 211 | O14994 | |
| RFLGRFGLQPHKTKL | 91 | Q8IZ69 | |
| PSGFRKFLVHNVKEL | 71 | P62910 | |
| ELLFDGIKKHRVTLP | 16 | Q9BTM9 | |
| AFKVLHDKQRGPLVF | 371 | Q969S9 | |
| FRKHTKLLIVGVFLL | 531 | Q9GZN6 | |
| KRHQLGKNFFEPTLL | 411 | P51649 | |
| LKHGFLEEFITPIVK | 586 | Q02880 | |
| KIIKEHRVFFSDKGP | 1056 | Q8NF91 | |
| FTLKEKGHLLRLPAA | 196 | Q7L2K0 | |
| FLTLHGGKKAPFRIQ | 436 | A0AVI2 | |
| KPSGVHLKLVLRFSD | 216 | Q96MK3 | |
| PAKHAGEILKFLGRE | 561 | Q9H156 | |
| VKPRKDAHLFSIGAI | 841 | Q9P2F8 | |
| LKHIDLRKTPSLEFG | 286 | Q9Y2E8 | |
| RKIHLFDIDVPGKIT | 111 | Q9NQR4 | |
| KDFVLKYALPLVGHR | 386 | P13667 | |
| VFHPFLDEILIGKIK | 76 | Q9Y535 | |
| VVLFVLLQPKLKSFH | 136 | Q92537 | |
| FHLLPSSVKFGVLKE | 2076 | Q6Q759 | |
| VKPSGHLFFRKLGNL | 301 | Q5VW32 | |
| KGRKPFLLAAERGHV | 201 | A6NHY2 | |
| PAGTLKIIDRKKHIF | 546 | Q9UKU0 | |
| IEHRDKKGFTPLILA | 1081 | Q8IWZ3 | |
| GTIFAELATKKPLFH | 191 | P06493 | |
| HRVAGIFPRLSFKDK | 446 | O96005 | |
| RIHLTPDFIAGKKLA | 131 | A8K7I4 | |
| PFLKEKTRKRIFLHG | 216 | Q5SYC1 | |
| AILKFFHKVRAGQPL | 246 | Q9ULP9 | |
| KLLFRVFTAPFHKVG | 376 | Q9UBH6 | |
| LKEAVILPIKFPHLF | 146 | O75351 | |
| TTLPKFREVGHLLKE | 216 | P56706 | |
| SIVKYFKERLHLPIG | 261 | Q9NRF8 | |
| FLRKKVSEAHLPSGI | 76 | O00295 | |
| GRFIKSHVIKLSPDE | 106 | Q6ZWK6 | |
| RGHLVLKSFKDTPLE | 246 | Q96AN5 | |
| KGHEFSIPYVELKIR | 1261 | Q9UQP3 | |
| GFKKLHGRSFDDPIV | 66 | O95757 | |
| TILELARYFLKHGPK | 371 | Q96IC2 | |
| VFVFHRLKIKQILPT | 201 | Q8N394 | |
| VLASSKGRKVPRHFL | 301 | Q5TEJ8 | |
| ITFLKPGVFEDLHRL | 186 | Q9HBX9 | |
| HIAKIFEKPVLGALA | 1411 | O95359 | |
| PFLKSKLLERVFVHG | 256 | P12271 | |
| FLGALDLAKKRVHPD | 141 | P40126 | |
| LAKEIGDAKFLHFLP | 326 | Q9NYK1 | |
| IRLFKGHPETLEKFD | 31 | P02144 | |
| AVFFLLPKFHGVLKT | 2381 | P78527 | |
| RHPGVIFKALKALSD | 391 | Q9HBF4 | |
| SLGITEFLRKKEIHP | 441 | A8K0R7 | |
| SLFRGLPNLITHKKF | 76 | Q2TB10 | |
| KRFGLPFVLHLEKTI | 471 | Q70CQ4 | |
| HIRGSPFKLKVIRSA | 411 | Q9C040 | |
| TAKVPIVKFFHLRSG | 1101 | Q5VYS8 | |
| FQSKIHSRIGSFLKP | 516 | Q6NT04 | |
| GALFVEKFIEKPRHI | 231 | P11498 | |
| EALQFVPKRKHTGFL | 371 | Q7L0Y3 | |
| KNLRKTRELFVHGLP | 566 | Q08AF3 | |
| KGEKRAVSFHRFPLK | 16 | Q8WY91 | |
| RGLPALRHVFDKAKF | 76 | Q9BVW5 | |
| GLFIRKPFIKFICHT | 356 | Q9UBN4 | |
| PEKLGSLFVKHERRL | 2041 | O75962 | |
| PSLVILGHYFKKRLG | 186 | Q8TF71 | |
| LEHPNVLKFIGVLYK | 391 | P53667 | |
| PDGETRKIKHLRVFF | 191 | P32418 |